Get started
Author

Cédric Pastoret

Observed names: C. Pastoret, Cedric Pastoret, PASTORET, Cédric, Pastoret, Cédric
Observed institutions: Hôpital Necker-Enfants Malades, Inserm, Masaryk University, Centre Hospitalier Universitaire Vaudois, Centre Hospitalier Universitaire de Nice, Université Rennes 2, Institut Necker Enfants Malades, La Ligue Contre le Cancer, University Hospital Brno, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Clermont-Ferrand, Établissement Français du Sang, Hôpital Saint-Louis, Centre Hospitalier Universitaire de Rennes, Microenvironment and B-cells: Immunopathology, Cell, Differentiation and Cancer, Université Rennes 1, Université de Rennes
ORCID: 0000-0002-5675-3154
Observed ORCID: 0000-0002-5675-3154
OpenAlex ID: A5081933349
Early Response–Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study
2017 · Jonathan Bond, Carlos Graux, et al. · Journal of Clinical Oncology · 169
IL-2 imprints human naive B cell fate towards plasma cell through ERK/ELK1-mediated BACH2 repression
2017 · Nicolas Hipp, Hannah Symington, et al. · Nature Communications · 116
PDF
STAT3 mutation impacts biological and clinical features of T-LGL leukemia
2017 · Antonella Teramo, Gregorio Barilà, et al. · Oncotarget · 80
PDF
PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome
2018 · Marie Passet, Nicolas Boissel, et al. · Blood · 78
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation
2020 · Damien Luque Paz, Rébecca Jouanneau-Courville, et al. · Blood Advances · 77
PDF
Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells
2021 · Cédric Pastoret, Fabienne Desmots, et al. · Blood · 63
PFMG2025–integrating genomic medicine into the national healthcare system in France
2025 · Caroline Abadie, Aldja Abderrahmane, et al. · The Lancet Regional Health - Europe · 57
PDF
High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL
2022 · Aurelie Cabannes-Hamy, Eolia Brissot, et al. · Haematologica · 44
PDF
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX
2025 · Vincent Jachiet, Olivier Kosmider, et al. · Blood · 41
PDF
Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53 -Mutant Clonal Hematopoiesis
2023 · Rathana Kim, Hugo Bergugnat, et al. · Blood Cancer Discovery · 37
PDF
The Need for a Consensus Next‐generation Sequencing Panel for Mature Lymphoid Malignancies
2019 · Pierre Sujobert, Yannick Le Bris, et al. · HemaSphere · 36
Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma
2018 · Fabienne Desmots, Mikaël Roussel, et al. · Clinical Cancer Research · 36
PDF
Genetic alterations and MRD refine risk assessment for KMT2A -rearranged B-cell precursor ALL in adults: a GRAALL study
2023 · Rathana Kim, Hugo Bergugnat, et al. · Blood · 35
PDF
Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing
2016 · Cedric Pastoret, Roch Houot, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 34
Blinatumomab during Consolidation in High-Risk Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL) Adult Patients: A Two-Cohort Comparison within the Graall-2014/B Study
2022 · Nicolas Boissel, Francoise Huguet, et al. · Blood · 26
Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients
2022 · Gregorio Barilà, Angela Grassi, et al. · Blood · 25
PDF
Frontline Consolidation with Blinatumomab for High-Risk Philadelphia-Negative Acute Lymphoblastic Adult Patients. Early Results from the Graall-2014-QUEST Phase 2
2021 · Nicolas Boissel, Francoise Huguet, et al. · Blood · 24
Evaluation of FMH QuikQuant for the detection and quantification of fetomaternal hemorrhage
2012 · Cedric Pastoret, Jerome Le Priol, et al. · Cytometry Part B Clinical Cytometry · 22
PDF
Age-adapted chemotherapy and MRD-oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial
2025 · Nicolas Boissel, Sylvie Chevret, et al. · Blood · 16
Large granular lymphocyte leukemia: a clonal disorder with autoimmune manifestations
2024 · Tony Marchand, Cédric Pastoret, et al. · Hematology · 15
PDF
Large granular lymphocyte leukemia: An indolent clonal proliferative disease associated with an array of various immunologic disorders
2023 · G. Drillet, C. Pastoret, et al. · La Revue de Médecine Interne · 15
In Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL), Age-Adapted Chemotherapy Intensity and MRD-Driven Transplant Indication Significantly Reduces Treatment-Related Mortality (TRM) and Improves Overall Survival - Results from the Graall-2014 Trial
2022 · Nicolas Boissel, Francoise Huguet, et al. · Blood · 14
T-cell large granular lymphocytic leukemia
2015 · Tony Marchand, Cédric Pastoret, et al. · Hématologie · 14
Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemia
2024 · Tony Marchand, Cédric Pastoret, et al. · British Journal of Haematology · 13
Prospective, Multicentric Phase II Randomized Trial Comparing the Efficacy of Methotrexate or Cyclophosphamide in Large Granular Lymphocytic Leukemia: A French National Study. Report on the Interim Analysis
2019 · Thierry Lamy, Cedric Pastoret, et al. · Blood · 13
Works count: 97
Citation count: 1,287
H-index: 18
I10-index: 31
Year
Topic
Type